PathAI
PathAI is a leading global provider of AI-powered pathology solutions that aims to improve the accuracy and reproducibility of histology assessment to accelerate drug development. Our AIM-MASH AI Assist is the first and only AI-assisted scoring tool qualified by both the FDA and EMA for enrollment and endpoint assessment, and is clinically validated on over 1,400 MASH trial biopsies. Exploratory products such as LiverExplore aid biomarker discovery and capture MoA with quantitative, cellular characterization of tissues and fibrosis. Our GCP/GCLP-compliant pathology laboratory and platform enable end-to-end clinical trial support.
